Barbara Willekens
University of Antwerp(BE)Antwerp University Hospital(BE)Infectious Diseases Institute(UG)
Publications by Year
Research Areas
Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Immunotherapy and Immune Responses, Polyomavirus and related diseases, Long-Term Effects of COVID-19
Most-Cited Works
- → Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease(2021)108 cited
- → Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial(2022)106 cited
- → Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial(2020)102 cited
- → Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration(2019)97 cited
- → Neurotrophic Factors as Regenerative Therapy for Neurodegenerative Diseases: Current Status, Challenges and Future Perspectives(2023)84 cited
- → Improving fatigue in multiple sclerosis by smartphone-supported energy management: The MS TeleCoach feasibility study(2018)